Member Info for ratcliffewriter

A million or so full ask late declared trades is most encouraging. I would say that Knowlesi's bazooka must have gone off, but last heard he was waiting for 3p or less.

It's because the spread is shown as 17/17.50 so any trade below the mid price will show as a sell, regardless of what it really is.

Loads of buys of varying sizes all showing as sells!

There may be 130 odd million shares in ValiRx, but about 20 percent of those were issued just a few months ago at 6p each, so a rise of about 220 percent is needed for a fifth of all shares in issue just to break even. The money raised from those shares has largely gone, spent on salaries and day-to-day running costs, given a return of......nothing. in fact negative. The majority of negative posters on here live in the past simply because that was when there had been less dilution, less consolidations, and at least a glimmer of ultimately ill-founded hope that there might be some prospect of success. Or even income that exceeded expenses.

Every seller has their reasons, but possibly something that rhymes with 'frolics'?

Don't forget to stack the logs on your south facing patio. Meanwhile I'm going to shout at the squirrels.

More.

Good idea. And I can blather on about wildlife in MY garden at various TIMES OF the year.

Quite a refreshingly notable absence of the self-declared 'astute', ever since the sp started pushing upwards. Probably just a coincidence.

Someone's certainly managed to have a spring clean! All I'd said was that after almost 4 years of dead silence I find it hard to believe anyone has any genuine enthusiasm for 201, especially after what was said would happen after the late 2020 RNS, none of which has seen the light of day.

"It is unclear based on the little publicly available evidence whether the combination is a significant step forward. BioNTech and Regeneron are yet to share the response results...."

Imagine the reaction here if we had the same comment about our trial results...

I did wonder how long it would take to lift the rock.

Bear in mind that if sclp is set up and organised to go it alone (as seems to be very much the case) then IF a big pharma wanted to buy them out it would have to be a massive (loke really massive) offer, assuming everything is looking as rosy as one might hope. If not, then bring on an independent scancell with loads of lucrative licensing and partnership deals. I can wait...

With Redmile and Vulpes on the board I'm confident they will do the best they can for shareholders, them being shareholders and all.

Positivity about the future has transformed in recent months. It gets ever more intriguing and exciting. (Other opinions are also available but in much shorter supply than of old)

With non trials going on and no decent datae from the very few carried out years ago, and just a phone call every few months to theorem to ask if there's any news yet (there never is) I'd consider anyone who wants a hefty salary in return for burger all is ideally suited to the job. Might apply myself if the next placing fills the coffers few another few months. Or Nomlungu and I could do a job share perhaps?

Steady on GF - I was almost tempted to say that maybe 'somebody knows something', but as I recall that can only be said by a 'balanced' poster in pressing home negative sentiment. If I were to say it as a shareholder and optimist, I would naturally be a 'delusional happy clapper', and more recently a 'buffoon.'

It's worth remembering how much wailing and gnashing of teeth there was from some posters when excellent news was presented in very dry, unenthusiastic terms in many an RNS. The tone of this latest RNS is far more what was being asked for, so maybe reflects a much higher level of excitement and (I hope) proximity of breakthrough news. But as ever, I'll watch and wait....

I wonder if they will then pay her as a consultant to the company - 2 days a week, 200 grand a year....?

Rearranging the deck chairs on the Titanic.